TOKYO, Oct. 22, 2018 /PRNewswire/ — Anaeropharma Science Inc. headquartered in Tokyo (hereinafter “Anaeropharma”) announced on October 22 that Anaeropharma Science and Chugai Pharmaceutical Co., Ltd. headquartered in Tokyo (hereinafter “Chugai”) have concluded a collaborative research…

View more at https://www.prnewswire.com:443/news-releases/anaeropharma-science-signs-collaborative-research-agreement-with-chugai-on-creation-of-novel-oncology-drugs-using-bifidobacterium-300734952.html